FATE THERAPEUTICS INC (FATE) Shareholders’ equity 2016–2025
FATE THERAPEUTICS INC (FATE) shareholders’ equity at each fiscal year-end, per SEC filings.
$207.2MFY2025 · since FY2016: $73.2M → $207.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $207.2M | -35.0% |
| FY2024 | $318.7M | -13.5% |
| FY2023 | $368.4M | -23.9% |
| FY2022 | $483.9M | -28.7% |
| FY2021 | $678.8M | +76.6% |
| FY2020 | $384.4M | +57.1% |
| FY2019 | $244.8M | +52.5% |
| FY2018 | $160.5M | +107.9% |
| FY2017 | $77.2M | +5.5% |
| FY2016 | $73.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice